KURA financials
Kura Oncology (KURA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
KURA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $67.48M | $67.42M | -$303.63M | -$278.67M | -3.18 |
| 2024 | $53.88M | $53.88M | -$193.19M | -$173.98M | -2.02 |
| 2023 | $0.00 | -$849.00K | -$165.80M | -$152.63M | -2.08 |
| 2022 | $0.00 | $0.00 | -$139.87M | -$135.84M | -2.03 |
| 2021 | $0.00 | $0.00 | -$131.26M | -$130.47M | -1.97 |
| 2020 | $0.00 | -$194.00K | -$91.90M | -$89.62M | -1.69 |
- KURA revenue was $67.48M in fiscal 2025, net income -$278.67M.
Updated 2026-11-03 11:33 UTC